Skip to content

Clinical trials

Phase 1 Lymphoma, T-Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 1 Country / region: United Kingdom Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Prelude Therapeutics1
Seagen Inc.1
Valerio Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell4
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Chronic2
Lymphoma2
Lymphoma, B-Cell2
Recurrence2
Adenosarcoma1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.